Last 12 months
Inside the activity.
0 purchase rows · 54 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2017 Filed Oct 3, 2017 00:19 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
Exercise / conversionCommon Stock | 5,300 | $44.62 | $236,459.50 |
DisclosureSEC source: 0001225208-17-015648 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,908.1926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 21:14 UTC |
Wood Larry LCVP, THV Replacement
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 18,960 | $0.00 Strike: $35.79 | $0.00 |
DisclosureSEC source: 0001225208-17-015095 · doc4.xml · derivative · entry 5 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,880 Underlying: Common Stock · 18,960 shares Expires 2020-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 21:14 UTC |
Wood Larry LCVP, THV Replacement
|
SaleCommon Stock | 10,447 | $112.79 | $1,178,295.19 |
DisclosureSEC source: 0001225208-17-015095 · doc4.xml · nonDerivative · entry 3 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,848.4338 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $112.66 to $112.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 21:14 UTC |
Wood Larry LCVP, THV Replacement
|
SaleCommon Stock | 8,513 | $112.32 | $956,150.36 |
DisclosureSEC source: 0001225208-17-015095 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,295.4338 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $111.66 to $112.64. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 21:14 UTC |
Wood Larry LCVP, THV Replacement
|
Exercise / conversionCommon Stock | 18,960 | $35.79 | $678,483.60 |
DisclosureSEC source: 0001225208-17-015095 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,808.4338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:15 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 32,900 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-014806 · doc4.xml · derivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,600 Underlying: Common Stock · 32,900 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person, and reflects 21,800 shares that were previously directly held but are now held indirectly by the Reporting Person's Living Trust. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:15 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 32,900 | $112.45 | $3,699,542.49 |
DisclosureSEC source: 0001225208-17-014806 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,330.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $112.06 to $112.87. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person, and reflects 21,800 shares that were previously directly held but are now held indirectly by the Reporting Person's Living Trust. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:15 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 32,900 | $44.62 | $1,467,833.50 |
DisclosureSEC source: 0001225208-17-014806 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,230.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person, and reflects 21,800 shares that were previously directly held but are now held indirectly by the Reporting Person's Living Trust. Read SEC document |
| August 30, 2017 Filed Aug 30, 2017 21:38 UTC |
Wood Larry LCVP, THV Replacement
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 18,960 | $0.00 Strike: $35.79 | $0.00 |
DisclosureSEC source: 0001225208-17-014420 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,840 Underlying: Common Stock · 18,960 shares Expires 2020-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| August 30, 2017 Filed Aug 30, 2017 21:38 UTC |
Wood Larry LCVP, THV Replacement
|
SaleCommon Stock | 18,960 | $111.81 | $2,119,965.00 |
DisclosureSEC source: 0001225208-17-014420 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,848.4338 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $111.57 to $112.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| August 30, 2017 Filed Aug 30, 2017 21:38 UTC |
Wood Larry LCVP, THV Replacement
|
Exercise / conversionCommon Stock | 18,960 | $35.79 | $678,483.60 |
DisclosureSEC source: 0001225208-17-014420 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,808.4338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 21:37 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 5,300 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-014419 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,100 Underlying: Common Stock · 5,300 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 21:37 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
SaleCommon Stock | 5,300 | $112.15 | $594,401.36 |
DisclosureSEC source: 0001225208-17-014419 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,608.1926 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $111.78 to $112.68. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 21:37 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
Exercise / conversionCommon Stock | 5,300 | $44.62 | $236,459.50 |
DisclosureSEC source: 0001225208-17-014419 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,908.1926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| August 09, 2017 Filed Aug 10, 2017 21:15 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 32,900 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-013714 · doc4.xml · derivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,500 Underlying: Common Stock · 32,900 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| August 09, 2017 Filed Aug 10, 2017 21:15 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 32,900 | $115.99 | $3,816,103.90 |
DisclosureSEC source: 0001225208-17-013714 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,130.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $115.44 to $116.43. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| August 09, 2017 Filed Aug 10, 2017 21:15 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 32,900 | $44.62 | $1,467,833.50 |
DisclosureSEC source: 0001225208-17-013714 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,030.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 25,000 | $0.00 Strike: $35.79 | $0.00 |
DisclosureSEC source: 0001225208-17-013379 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,800 Underlying: Common Stock · 25,000 shares Expires 2020-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person; and it includes 60,479 shares previously owned directly which are now owned by trust. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
SaleCommon Stock | 25,000 | $116.00 | $2,900,037.50 |
DisclosureSEC source: 0001225208-17-013379 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,608.1926 F2 · price: This transaction was executed in multiple trades at prices ranging from $116.00 to $116.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person; and it includes 60,479 shares previously owned directly which are now owned by trust. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
Exercise / conversionCommon Stock | 25,000 | $35.79 | $894,625.00 |
DisclosureSEC source: 0001225208-17-013379 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,608.1926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person; and it includes 60,479 shares previously owned directly which are now owned by trust. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 21:39 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 32,900 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-013089 · doc4.xml · derivative · entry 6 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,400 Underlying: Common Stock · 32,900 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 21:39 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 29,300 | $114.72 | $3,361,260.84 |
DisclosureSEC source: 0001225208-17-013089 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,130.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $114.1550 to $115.14. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 21:39 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 3,600 | $115.42 | $415,512.72 |
DisclosureSEC source: 0001225208-17-013089 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,430.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $115.19 to $115.71. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 21:39 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 32,900 | $44.62 | $1,467,833.50 |
DisclosureSEC source: 0001225208-17-013089 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,030.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 21:38 UTC |
Szyman Catherine M.CVP, Critical Care & Vascular
|
SaleCommon Stock | 4,681 | $115.78 | $541,966.18 |
DisclosureSEC source: 0001225208-17-013088 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care & Vascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,329.8019 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 21:38 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 5,300 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-013087 · doc4.xml · derivative · entry 7 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,400 Underlying: Common Stock · 5,300 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 21:38 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
SaleCommon Stock | 2,500 | $114.16 | $285,394.00 |
DisclosureSEC source: 0001225208-17-013087 · doc4.xml · nonDerivative · entry 4 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,239.1926 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F5 · price: This transaction was executed in multiple trades at prices ranging from $113.58 to $114.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 21:38 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
SaleCommon Stock | 2,500 | $115.05 | $287,626.50 |
DisclosureSEC source: 0001225208-17-013087 · doc4.xml · nonDerivative · entry 3 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,739.1926 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $114.63 to $115.5950. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 21:38 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
SaleCommon Stock | 300 | $115.86 | $34,759.02 |
DisclosureSEC source: 0001225208-17-013087 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,239.1926 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $115.69 to $115.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 21:38 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
Exercise / conversionCommon Stock | 5,300 | $44.62 | $236,459.50 |
DisclosureSEC source: 0001225208-17-013087 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,539.1926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 21:41 UTC |
Wood Larry LCVP, THV Replacement
|
Tax withholdingCommon Stock | 592 | $118.17 | $69,956.64 |
DisclosureSEC source: 0001225208-17-012563 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,848.4338 F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 22:47 UTC |
Ullem Scott B.CVP, CFO
|
Tax withholdingCommon Stock | 297 | $118.17 | $35,096.49 |
DisclosureSEC source: 0001225208-17-012564 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,666 F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person; and it reflects 271 shares that were previously reported as directly held but are currently held in trust. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 20:08 UTC |
Szyman Catherine M.CVP, Critical Care & Vascular
|
SaleCommon Stock | 4,716 | $118.11 | $557,006.76 |
DisclosureSEC source: 0001225208-17-011949 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care & Vascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,921.1453 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 20:05 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 5,600 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-011948 · doc4.xml · derivative · entry 6 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,700 Underlying: Common Stock · 5,600 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 20:05 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
SaleCommon Stock | 3,000 | $116.89 | $350,673.60 |
DisclosureSEC source: 0001225208-17-011948 · doc4.xml · nonDerivative · entry 3 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,182.6555 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $116.20 to $117.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 20:05 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
SaleCommon Stock | 2,600 | $117.45 | $305,360.90 |
DisclosureSEC source: 0001225208-17-011948 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,182.6555 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $117.20 to $117.91. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 20:05 UTC |
BOBO DONALD E JRCVP, Heart Valve Therapy
|
Exercise / conversionCommon Stock | 5,600 | $44.62 | $249,844.00 |
DisclosureSEC source: 0001225208-17-011948 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,782.6555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:47 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 32,900 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-011063 · doc4.xml · derivative · entry 6 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,300 Underlying: Common Stock · 32,900 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:47 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 16,935 | $117.84 | $1,995,562.82 |
DisclosureSEC source: 0001225208-17-011063 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,130.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $117.15 to $118.14. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:47 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 15,965 | $118.29 | $1,888,434.39 |
DisclosureSEC source: 0001225208-17-011063 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,065.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $118.15 to $118.61. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:47 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 32,900 | $44.62 | $1,467,833.50 |
DisclosureSEC source: 0001225208-17-011063 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,030.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Read SEC document |
| May 31, 2017 Filed May 31, 2017 22:49 UTC |
Verguet Patrick BCVP, Europe
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 10,000 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-010625 · doc4.xml · derivative · entry 3 Verguet Patrick B · CIK 0001308771 · CVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,800 Underlying: Common Stock · 10,000 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Read SEC document |
| May 31, 2017 Filed May 31, 2017 22:49 UTC |
Verguet Patrick BCVP, Europe
|
SaleCommon Stock | 10,000 | $114.88 | $1,148,760.00 |
DisclosureSEC source: 0001225208-17-010625 · doc4.xml · nonDerivative · entry 2 Verguet Patrick B · CIK 0001308771 · CVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,137.1496 F2 · price: This transaction was executed in multiple trades at prices ranging from $114.7519 to $115.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Read SEC document |
| May 31, 2017 Filed May 31, 2017 22:49 UTC |
Verguet Patrick BCVP, Europe
|
Exercise / conversionCommon Stock | 10,000 | $44.62 | $446,150.00 |
DisclosureSEC source: 0001225208-17-010625 · doc4.xml · nonDerivative · entry 1 Verguet Patrick B · CIK 0001308771 · CVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,137.1496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Read SEC document |
| May 19, 2017 Filed May 19, 2017 20:25 UTC |
Verguet Patrick BCVP, Europe
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 10,000 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-010120 · doc4.xml · derivative · entry 7 Verguet Patrick B · CIK 0001308771 · CVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock · 10,000 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Read SEC document |
| May 19, 2017 Filed May 19, 2017 20:25 UTC |
Verguet Patrick BCVP, Europe
|
SaleCommon Stock | 10,000 | $113.13 | $1,131,346.00 |
DisclosureSEC source: 0001225208-17-010120 · doc4.xml · nonDerivative · entry 5 Verguet Patrick B · CIK 0001308771 · CVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,137.1496 F4 · price: This transaction was executed in multiple trades at prices ranging from $113.00 to $113.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Read SEC document |
| May 19, 2017 Filed May 19, 2017 20:25 UTC |
Verguet Patrick BCVP, Europe
|
Exercise / conversionCommon Stock | 10,000 | $44.62 | $446,150.00 |
DisclosureSEC source: 0001225208-17-010120 · doc4.xml · nonDerivative · entry 4 Verguet Patrick B · CIK 0001308771 · CVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,137.1496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:25 UTC |
Verguet Patrick BCVP, Europe
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 8,000 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001225208-17-010120 · doc4.xml · derivative · entry 6 Verguet Patrick B · CIK 0001308771 · CVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,800 Underlying: Common Stock · 8,000 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:25 UTC |
Verguet Patrick BCVP, Europe
|
SaleCommon Stock | 8,000 | $113.15 | $905,220.80 |
DisclosureSEC source: 0001225208-17-010120 · doc4.xml · nonDerivative · entry 3 Verguet Patrick B · CIK 0001308771 · CVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,137.1496 F3 · price: This transaction was executed in multiple trades at prices ranging from $113.1340 to $113.1550. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:25 UTC |
Verguet Patrick BCVP, Europe
|
SaleCommon Stock | 4,631 | $113.21 | $524,271.81 |
DisclosureSEC source: 0001225208-17-010120 · doc4.xml · nonDerivative · entry 2 Verguet Patrick B · CIK 0001308771 · CVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,137.1496 F2 · price: This transaction was executed in multiple trades at prices ranging from $113.2091 to $113.2150. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.